The Effectiveness of "MaRiTensi" in Increasing Self-Care and Blood Pressure Control: Randomized Controlled Trial
"MaRiTensi"
"MaRiTensi" SELF MANAGEMENT APPLICATION FOR HYPERTENSION PATIENTS BASED ON M-HEALTH Its Effectiveness In Increasing Self- Care And Controlling Pressure Blood: Randomized Controlled Trial
1 other identifier
interventional
99
1 country
3
Brief Summary
This study aims to know the effectiveness of "MaRiTensi" in improving knowledge, motivation, efficacy, self-care and blood pressure control for hypertension patients. This study hypothesizes that MaRiTensi effectively increases the knowledge, motivation, self-efficacy and self-care of hypertensive patients and reduces blood pressure in the intervention group compared to the control group. Respondent recruitment is as follows:
- 1.The respondent candidate will be identified based on data on record medical
- 2.Appropriate respondent candidates' criteria inclusion and exclusion contacted for given informed consent
- 3.Prospective respondents who are willing to participate and fulfill the criteria for pressure blood moment measurement will request signed consent
- 4.Respondents fill in the basic data and recapitulate by the assistant researcher
- 5.Done randomization for allocation of group interventions and group control
- 6.Respondents given envelope closed (using sequentially numbered, opaque sealed envelopes (SNOSE) method )
- 7.Respondents' group intervention was given maintenance by Hospital or health center standard-added intervention using MaRiTensi by conditions; meanwhile, group control was provided care by Hospital or health center standards.
Trial Health
Trial Health Score
Automated assessment based on enrollment pace, timeline, and geographic reach
participants targeted
Target at P50-P75 for not_applicable
Started Oct 2023
Shorter than P25 for not_applicable
3 active sites
Health score is calculated from publicly available data and should be used for screening purposes only.
Trial Relationships
Click on a node to explore related trials.
Study Timeline
Key milestones and dates
First Submitted
Initial submission to the registry
September 11, 2023
CompletedFirst Posted
Study publicly available on registry
September 22, 2023
CompletedStudy Start
First participant enrolled
October 11, 2023
CompletedPrimary Completion
Last participant's last visit for primary outcome
April 28, 2024
CompletedStudy Completion
Last participant's last visit for all outcomes
April 28, 2024
CompletedJuly 9, 2024
July 1, 2024
7 months
September 11, 2023
July 8, 2024
Conditions
Keywords
Outcome Measures
Primary Outcomes (5)
The level of knowledge of hypertensive patients about hypertension
Everything that hypertensive patients know about, definitions, medical drugs, drug adherence, lifestyle, diet, and complications as measured by 22 questions using the Indonesian version of the HK-LS questionnaire
up to 12 weeks
The motivation of hypertensive patients
The desire of hypertensive patients to take action to manage their hypertension as measured by 20 questions using the Indonesian version of the HBP-SCP questionnaire
up to 12 weeks
Self-efficacy of hypertensive patients
A hypertensive patient's belief that he can manage his hypertension well as measured by 20 questions using the Indonesian version of the HBP-SCP questionnaire
up to 12 weeks
Self-care of hypertensive patients
Actions initiated and performed by hypertensive patients to manage their disease as measured by 20 questions about self-management of hypertensive patients using the Indonesian version of the HBP-SCP questionnaire
up to 12 weeks
Blood Pressure Control
A condition in which hypertensive patients can control their blood pressure. The criterion that blood pressure is under control if it meets 1 of the following criteria: 1. There were no additional antihypertensive drugs during the study period 2. There were no additional doses of antihypertensive drugs during the study period 3. Blood pressure \<140 mmHg at the first and second evaluation
up to 12 weeks
Study Arms (2)
MariTensi app and usual care
EXPERIMENTALPatients use the MaRitensi application to manage their hypertension by utilizing various menus in the application and continue receiving treatment as usual for 12 weeks.
Usual care
NO INTERVENTIONThe patient was not given the MaRitensi application and only received treatment as usual.
Interventions
MaRiTensi is a mobile health-based hypertension self-management application used on Android smartphones. MariTensi provides facilities for recording blood pressure, BMI, activity, examination results, education about hypertension, consultations, reminders and community chat.
Eligibility Criteria
You may qualify if:
- A patient registered in the medical record of RSPR, the doctor diagnosed with hypertension based on ICD 10: I10; Age 18 to \<60 years; owning and being able to use a smartphone; living in Yogyakarta during the study period; blood pressure ≥ 140/90 mmHg measured at the time of visit.
You may not qualify if:
- According to the doctor's diagnosis based on ICD 10:
- Renal failure (ICD: N17-N19)
- Diabetes Mellitus (ICD: E10-E14.9)
- Stroke (ICD: I60-I69.8)
- Acute Miocard Infarction (AMI) (ICD: I21-I21.9)
- Heart Failure (ICD: I50-I50.9)
- Cancer (ICD: C00-C97)
- Dementia (ICD: F00-F04)
- Mental disorders (ICD: F05-F99.9)
- Thyroid Disease (ICD: E00-E07.9)
- Human Immunodeficiency Virus (HIV) or Acquired Immunodeficiency Syndrome (AIDS) (ICD: B20)
- Movement limitations: Hernia Nucleus Pulposus (HNP) (ICD: M50-M51.9); Piriformis Syndrome (ICD: G57-G57.9); Low Back Pain (LBP) (ICD: M54-M54.9); Frozen Shoulder (ICD: M75-75.9)
Contact the study team to confirm eligibility.
Sponsors & Collaborators
- Chatarina Setya Widyastutilead
- Gadjah Mada Universitycollaborator
Study Sites (3)
Puskesmas Depok 2
Sleman, D.I Yogyakarta, 55283, Indonesia
Puskesmas Pakem
Sleman, DI Yogyakarta, 55582, Indonesia
Panti Rapih Hospital
Yogyakarta, 55223, Indonesia
Related Publications (1)
Widyastuti CS, Dinarti LK, Aulawi K, Lazuardi L. Effectiveness of mHealth on self-care profile and blood pressure among patients with hypertension in Indonesia: A single-blind randomized controlled trial. Belitung Nurs J. 2025 May 27;11(3):294-304. doi: 10.33546/bnj.3760. eCollection 2025.
PMID: 40438651DERIVED
MeSH Terms
Conditions
Condition Hierarchy (Ancestors)
Study Officials
- STUDY CHAIR
Chatarina S Widyastuti
Gadjah Mada University
Study Design
- Study Type
- interventional
- Phase
- not applicable
- Allocation
- RANDOMIZED
- Masking
- DOUBLE
- Who Masked
- CARE PROVIDER, OUTCOMES ASSESSOR
- Masking Details
- In the research, the third stage will do double-blinding for the care provider and outcome assessor, who will evaluate blood pressure and questionnaires. Allocation concealment for dividing into groups, intervention and control will use the SNOSE (sequentially numbered, opaque sealed envelopes ) method. The envelope closed will be sorted by order randomization, given paper carbon with appearance. The same is true for envelopes with the inscription intervention or control.
- Purpose
- SUPPORTIVE CARE
- Intervention Model
- PARALLEL
- Sponsor Type
- OTHER
- Responsible Party
- SPONSOR INVESTIGATOR
- PI Title
- S.Kep.,Ns.,M.Kep.,Sp.Kep.M.B
Study Record Dates
First Submitted
September 11, 2023
First Posted
September 22, 2023
Study Start
October 11, 2023
Primary Completion
April 28, 2024
Study Completion
April 28, 2024
Last Updated
July 9, 2024
Record last verified: 2024-07
Data Sharing
- IPD Sharing
- Will share
- Shared Documents
- SAP
- Time Frame
- during study period
- Access Criteria
- numeric data for data analysis
Data share to other reseacher for data analysis because there is a mask in data analysis in this study